Position
Chief Executive Officer
Company
Arbutus
WarminsterBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a cure for people with chronic hepatitis B virus infection, today announced that William Collier will retire from his position as the Company’s President and Chief Executive Officer, and as a member of the Board of Directors, at the end of 2023. Michael J. McElhaugh, Co-founder and Chief Operating Officer of Arbutus, will serve as Interim President and Chief Executive Officer, effective January 1, 2024
Quick answer
Arbutus Announces CEO, William Collier, to Retire December 31, 2023 (November 7, 2023). Arbutus is based in Warminster, Pennsylvania, United States.
- What did Arbutus announce on November 7, 2023?
- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a cure for people with chronic hepatitis B virus infection, today announced that William Collier will retire from his position as the Company’s President and Chief Executive Officer, and as a member of the Board of Directors, at the end of 2023.
- What does Arbutus do?
- Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which...
- Where is Arbutus based?
- Arbutus is based in Warminster, Pennsylvania, United States.
- Which similar companies made leadership changes around the same time?
- Madrigal Pharmaceuticals (November 10, 2023), vTv Therapeutics Inc. (November 2, 2023), Chimerix (November 16, 2023) and Dimerix Limited (October 23, 2023) also announced leadership changes within 45 days of Arbutus.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial Officer (November 10, 2023)
- vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer (November 2, 2023)
- Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer (November 16, 2023)
- Dimerix Limited Announces Appointment of Dr David Fuller as Chief Medical Officer (October 23, 2023)
- Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer (November 28, 2023)
- Santhera Appoints Executive Committee Members as it Transitions into Commercial Stage (December 7, 2023)
Who to call at Arbutus, and when
A new leader at Arbutus brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Arbutus raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arbutus, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arbutus. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arbutus changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Arbutus changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.